2W4C
Human common-type acylphosphatase variant, A99
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 |
Temperature [K] | 287 |
Detector technology | IMAGE PLATE |
Collection date | 2006-09-30 |
Detector | RIGAKU IMAGE PLATE |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 24.604, 57.861, 59.095 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.340 - 1.520 |
R-factor | 0.198 |
Rwork | 0.196 |
R-free | 0.22800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2vh7 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.353 |
Data reduction software | MOSFLM |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.2.0005) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 14.310 | 1.520 |
High resolution limit [Å] | 1.520 | 1.520 |
Rmerge | 0.040 | 0.180 |
Number of reflections | 13607 | |
<I/σ(I)> | 30.7 | 9.2 |
Completeness [%] | 99.9 | 100 |
Redundancy | 2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 6 | 16MG/ML K99A IN 20MMTRIS, 0.2MNACL, PH7.5 K99A WAS CRYSTALLIZED IN 0.1M BIS-TRIS, 0.1M NAOAC, PH6.0 WITH 25% PEG3350 AS CYROPROTECTANT |